Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL

Christian H. Geisler, Mars B. van t’ Veer, Jesper Jurlander, Jan Walewski, Geir Tjønnfjord, Maija Itälä Remes, Eva Kimby, Tomas Kozak, Aaron Polliack, Ka Lung Wu, Shulamiet Wittebol, Martine C. J. Abrahamse-Testroote, Jeanette Doorduijn, Wendimagegn Ghidey Alemayehu, Marinus H. J. van Oers

Blood (2014) 123 (21): 3255–3262.

https://doi.org/10.1182/blood-2014-01-547737

Published: 2014

Includes: Supplemental data

Journal Articles

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

Blood (2012) 119 (19): 4467–4475.

https://doi.org/10.1182/blood-2011-11-393694

Published: 2012

Includes: Supplemental data

Journal Articles

Immunochemotherapy with Low-Dose Subcutaneous Alemtuzumab (A) Plus Oral Fludarabine and Cyclophosphamide (FC) Is Safe and Induces More and Deeper Complete Remissions in Untreated Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) Than Chemotherapy with FC Alone. An Early Analysis of the Randomized Phase-III HOVON68 CLL Trial

Christian H Geisler, MD, PhD, Mars MB van 't Veer, MD, PhD, Wim van Putten, MSc, Jesper Jurlander, MD.PHD, Jan Walewski, MD, PhD, Geir Tjonnfjord, MD, PHD, Maija Itälä-Remes, MD, PHD, Eva Kimby, M.D., Ph.D., Tomas Kozak, MD, PhD, Aaron Polliack, MD, Shulamiet Wittebol, MD, Fokje Spoelstra, PhD, Marinus H.J. Van Oers, MD, PhD

Blood (2011) 118 (21): 290.

https://doi.org/10.1182/blood.V118.21.290.290

Published: 2011

Journal Articles

The Composition of the B Cell Receptor Repertoire In 7428 Cases of Chronic Lymphocytic Leukemia: One Third Stereotyped, Two Thirds Heterogeneous - What Does This Mean?

Blood (2010) 116 (21): 43.

https://doi.org/10.1182/blood.V116.21.43.43

Published: 2010

Journal Articles

Chronic Lymphocytic Leukemia with Stereotyped IGHV4-59/IGKV3-20 B Cell Receptors: Another Manifestation of Hepatitis C Virus-Associated B Cell Lymphoproliferation?.

Efterpi Kostareli, Agnieszka Janus, Maria Gounari, Chrysoula Belessi, Sarka Pospisilova, David Oscier, Letizia Foroni, Paola Francia di Celle, Jesper Jurlander, Richard Rosenquist, Frederic Davi, Keith Thompson, Paolo Ghia, Kostas Stamatopoulos

Blood (2009) 114 (22): 2331.

https://doi.org/10.1182/blood.V114.22.2331.2331

Published: 2009

Journal Articles

LPL Is the Strongest Prognostic Factor in a Comparative Study of RNA-Based Markers in Chronic Lymphocytic Leukemia.

Mohd Arifin Kaderi, Meena Kanduri, Mahmoud Mansouri, Anne Mette Buhl, Marie Sevov, Nicola Cahill, Rebeqa Gunnarsson, Mattias Jansson, Karin Ekström Smedby, Henrik Hjalgrim, Gunnar Juliusson, Jesper Jurlander, Richard Rosenquist

Blood (2009) 114 (22): 1254.

https://doi.org/10.1182/blood.V114.22.1254.1254

Published: 2009

Journal Articles

A Different Ontogenesis for CLL Cases Carrying Stereotyped Antigen Receptors: Molecular and Computational Evidence

Nikos Darzentas, Anastasia Hadzidimitriou, Fiona Murray, Katerina Hatzi, Par Josefsson, Nikolaos Laoutaris, Carol Moreno, Achilles Anagnostopoulos, Jesper Jurlander, Athanasios Tsaftaris, Nicholas Chiorazzi, Chrysoula Belessi, Paolo Ghia, Richard Rosenquist, Frederic Davi, Kostas Stamatopoulos

Blood (2008) 112 (11): 777.

https://doi.org/10.1182/blood.V112.11.777.777

Published: 2008

Journal Articles

Final Results of a Phase II Danish Trial Testing Low Dose Total Body Irradiation Following Six Bi-Weekly RCHOP-14 Plus 2 Extra Rituximab in Elderly High risk Patients with Aggressive CD20+ Diffuse Large B-Cell Lymphoma (DLBCL).

Akmal Safwat, M.D., Lena Specht, M.D., Flemming Hansen, M.D., Mads Hansen, M.D., Jesper Jurlander, M.D., Francesco d’Amore, MD

Blood (2008) 112 (11): 1013.

https://doi.org/10.1182/blood.V112.11.1013.1013

Published: 2008

Journal Articles

High Resolution Screening of Copy-Number Alterations in Chronic Lymphocytic Leukemia Using Affymetrix 250K SNP-Arrays Reveals a Higher Complexity of Genomic Alterations in Patients with Unmutated IGHV Genes

Rebeqa Gunnarsson, MSc, Anders Isaksson, PhD, Hanna Göransson, MSc, Larry Mansouri, PhD, Mattias Jansson, PhD, Nicola Cahill, MSc, Karin Ekström Smedby, M.D., PhD, Jesper Jurlander, M.D., PhD, Gunnar Juliusson, M.D., PhD, Richard Rosenquist, M.D., PhD

Blood (2008) 112 (11): 3133.

https://doi.org/10.1182/blood.V112.11.3133.3133

Published: 2008

Journal Articles

Quality of Life in Diffuse Large B-Cell Lymphoma Patients Treated with CHOP-14 Based Chemotherapy Is Only Affected Temporarily

Dorte Tholstrup, MD, Jesper Jurlander, MD, PhD, Palle Bekker Jeppesen, MD, PhD, DrMSci, Peter de Nully Brown, MD, PhD

Blood (2008) 112 (11): 2384.

https://doi.org/10.1182/blood.V112.11.2384.2384

Published: 2008

Journal Articles

Early Results of a Phase II Trial Testing Low Dose Total Body Irradiation (LTBI) after Chemoimmunotherapy in Elderly High Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Akmal Safwat, MD, Lena Specht, M.D., Flemming Hansen, M.D., Mads Hansen, M.D., Jesper Jurlander, M.D., Anne Marie Boesen, M.D., Francesco d’Amore, M.D.

Blood (2007) 110 (11): 1296.

https://doi.org/10.1182/blood.V110.11.1296.1296

Published: 2007

Journal Articles

Screening for Copy Number Alterations and Loss of Heterozygosity in Chronic Lymphocytic Leukemia - A Comparative Study of Four Differently Designed, High Resolution Microarray Platforms.

Rebeqa Gunnarsson, MSc, Johan Staaf, MSc, Mattias Jansson, PhD, Anne Marie Ottesen, PhD, Hanna Göransson, MSc, Ulrika Liljedahl, PhD, Ulrik Ralfkiaer, MSc, Mahmoud Mansouri, PhD, Karin Ekström Smedby, MD, PhD, Henrik Hjalgrim, MD, PhD, Ann-Christine Syvänen, PhD, Åke Borg, PhD, Anders Isaksson, PhD, Jesper Jurlander, MD, PhD, Gunnar Juliusson, MD, PhD, Richard Rosenquist, MD, PhD

Blood (2007) 110 (11): 2084.

https://doi.org/10.1182/blood.V110.11.2084.2084

Published: 2007

Journal Articles

CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia

Pär Josefsson, Christian H. Geisler, Henrik Leffers, Jørgen H. Petersen, Mette K. Andersen, Jesper Jurlander, Anne Mette Buhl

Blood (2007) 109 (11): 4973–4979.

https://doi.org/10.1182/blood-2006-11-054916

Published: 2007

Journal Articles

Acquired Immunodeficiency and Malnutrition in Patients Treated with Bi-Weekly CHOP-Based Chemotherapy for Diffuse Large B-Cell Lymphoma.

Dorte Tholstrup, MD, Mads Hansen, MD, Dr.M.Sci., Peter De Nully Brown, MD, Ph.d., Jesper Jurlander, MD, Ph.d.

Blood (2006) 108 (11): 2443.

https://doi.org/10.1182/blood.V108.11.2443.2443

Published: 2006

Journal Articles

Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia

Anne Mette Buhl, Jesper Jurlander, Flemming S. Jørgensen, Anne Marie Ottesen, Jack B. Cowland, Lise Mette Gjerdrum, Brian V. Hansen, Henrik Leffers

Blood (2006) 107 (7): 2904–2911.

https://doi.org/10.1182/blood-2005-07-2615

Published: 2006

Includes: Supplemental data

Journal Articles

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma

Martin Hutchings, Annika Loft, Mads Hansen, Lars Møller Pedersen, Thora Buhl, Jesper Jurlander, Simon Buus, Susanne Keiding, Francesco D'Amore, Anne-Marie Boesen, Anne Kiil Berthelsen, Lena Specht

Blood (2006) 107 (1): 52–59.

https://doi.org/10.1182/blood-2005-06-2252

Published: 2006

Journal Articles

Validation of the Prognostic Significance of the Disease Specific Gene CLLU1 in Chronic Lymphocytic Leukemia.

Par Josefsson, MD, Jesper Jurlander, MD, PhD, Christian H. Geisler, MDD.MS, Lone B. Pedersen, Lone Bach, Mette K. Andersen, MD, Henrik Leffers, MS, Anne Mette Buhl, PhD

Blood (2005) 106 (11): 709.

https://doi.org/10.1182/blood.V106.11.709.709

Published: 2005

Journal Articles

A Novel and Disease Specific Gene in Chronic Lymphocytic Leukemia.

Anne Mette Buhl, PhD, Jesper Jurlander, MD, PhD, Lone B. Pedersen, Par Josefsson, MD, Christian H. Geisler, MD, DMsc, Henrik Leffers, MSc

Blood (2004) 104 (11): 770.

https://doi.org/10.1182/blood.V104.11.770.770

Published: 2004

Journal Articles

Efficacy and Safety of CHOP-14 in Elderly Patients with Very Poor Risk Diffuse Large B-Cell Lymphoma.

Dorte Tholstrup, MD, Peter de Nully Brown, MD, PhD, Mads Hansen, MD, DrMSci, Jesper Jurlander, MD, PhD

Blood (2004) 104 (11): 3307.

https://doi.org/10.1182/blood.V104.11.3307.3307

Published: 2004

Journal Articles

Long-Term Complete Molecular Remissions in Untreated Symptomatic Follicular Lymphoma Treated with Rituximab as Single Agent and in Combination with Interferon-alpha-2a: Analysis of Minimal Residual Disease in the Randomized Phase II Study M39035.

Jesper Jurlander, Christian Geisler, Hans Hagberg, Harald Holte, Tuula Lehtinen, Eva Kimby

Blood (2004) 104 (11): 1393.

https://doi.org/10.1182/blood.V104.11.1393.1393

Published: 2004

NARROW

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

The Composition of the B Cell Receptor Repertoire In 7428 Cases of Chronic Lymphocytic Leukemia: One Third Stereotyped, Two Thirds Heterogeneous - What Does This Mean?

Chronic Lymphocytic Leukemia with Stereotyped IGHV4-59/IGKV3-20 B Cell Receptors: Another Manifestation of Hepatitis C Virus-Associated B Cell Lymphoproliferation?.

LPL Is the Strongest Prognostic Factor in a Comparative Study of RNA-Based Markers in Chronic Lymphocytic Leukemia.

A Different Ontogenesis for CLL Cases Carrying Stereotyped Antigen Receptors: Molecular and Computational Evidence

Final Results of a Phase II Danish Trial Testing Low Dose Total Body Irradiation Following Six Bi-Weekly RCHOP-14 Plus 2 Extra Rituximab in Elderly High risk Patients with Aggressive CD20+ Diffuse Large B-Cell Lymphoma (DLBCL).

High Resolution Screening of Copy-Number Alterations in Chronic Lymphocytic Leukemia Using Affymetrix 250K SNP-Arrays Reveals a Higher Complexity of Genomic Alterations in Patients with Unmutated IGHV Genes

Quality of Life in Diffuse Large B-Cell Lymphoma Patients Treated with CHOP-14 Based Chemotherapy Is Only Affected Temporarily

Early Results of a Phase II Trial Testing Low Dose Total Body Irradiation (LTBI) after Chemoimmunotherapy in Elderly High Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Screening for Copy Number Alterations and Loss of Heterozygosity in Chronic Lymphocytic Leukemia - A Comparative Study of Four Differently Designed, High Resolution Microarray Platforms.

CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia

Acquired Immunodeficiency and Malnutrition in Patients Treated with Bi-Weekly CHOP-Based Chemotherapy for Diffuse Large B-Cell Lymphoma.

Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma

Validation of the Prognostic Significance of the Disease Specific Gene CLLU1 in Chronic Lymphocytic Leukemia.

A Novel and Disease Specific Gene in Chronic Lymphocytic Leukemia.

Efficacy and Safety of CHOP-14 in Elderly Patients with Very Poor Risk Diffuse Large B-Cell Lymphoma.

Long-Term Complete Molecular Remissions in Untreated Symptomatic Follicular Lymphoma Treated with Rituximab as Single Agent and in Combination with Interferon-alpha-2a: Analysis of Minimal Residual Disease in the Randomized Phase II Study M39035.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only